A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity ...

As the women’s NCAA March Madness tournament draws to a close, Eli Lilly is aiming for a slam dunk of its own. | As the women ...

After a Houston judge denied Johnson & Johnson’s third attempt to resolve approximately 90,000 talcum powder lawsuits through ...

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph ...

The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...

Patients are looking to pharmaceutical companies to offer healthcare services beyond just drug development, and, ideally, in ...

Drug delivery specialist SHL Medical opened the doors to its new $220 million autoinjector production facility in South ...

As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...

Nearly a year after a jury decided that Johnson & Johnson should be fined just over $150 million in a lawsuit alleging that ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so ...